Italian drugmakers Alfa Wasserman and Sigma-Tau said on Thursday they had agreed to merge pharmaceutical activities to create a domestic champion with sales of more than 900 million euros ($992 million).
In October sources told Reuters the two companies were in advanced talks to combine their Italian operations.